Day 2 Notes from the 42nd Annual J.P. Morgan Healthcare Conference
Sheppard Health Law
JANUARY 10, 2024
Perhaps we need to rethink how we as a country are approaching cancer care. They are not only doing the research and partnering, but they are building a life sciences industry campus to help companies launch and grow. I also was intrigued by Moffitt’s focus on T cell therapy research and commercialization.
Let's personalize your content